VOLUME 13 ISSUE 2 2003

MM Demet, F Deniz, E Şimşek, EO Taşkın, A Deveci
Psikotrop ilaç yazılma sıklığı ve ilaç etkileşimleri: sitokrom P450 sistemi
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):43-49

 
H Demirci, N Kosku, Y Çınar, C İlnem
Evaluation of coronary heart disease risk in patients with schizophrenia who were treated with typical antipsychotics
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):50-56

 
A Özbek, ÖG Bozabalı
The use of psychotropic medication in pre-schoolers
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):57-64

 
 
A Yıldız, N Gökmen, K Turgut, G Yücel, Z Tunca
Place of electroconvulsive therapy among the somatic treatments in a university clinic psychiatric inpatients
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):65-71
 
 
 
K Yazıcı, A Yazıcı, A Biçer, Ş Tot, G Şahin, V Buturak
The effect of anxiety and depression on quality of life in patients with chronic pain
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):72-77

 
 
E Eşel
Neurobiology of generalized anxiety disorder
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):78-87

 
 
S Kesebir, Ş Pırıldar
Reproductive and sexual functions in schizophrenia: effects of antipsychotic treatment
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):88-93

 
 
AE Danacı, S Mızrak, Z Hekimsoy, İ İçelli
Diabetes mellitus due to olanzapine use: a case report
Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2003;13(2):94-96